Prognostic value of nutritional and inflammatory markers in patients with hepatocellular carcinoma who receive immune checkpoint inhibitors

The emergence of immune checkpoint inhibitors (ICIs) has provided a new treatment option for patients with hepatocellular carcinoma (HCC). However, further evaluation is needed for determining biomarkers for the use of ICIs. The present study evaluated the prognostic value of certain nutritional and...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chunxun, Zhao, Haoran, Zhang, Rujia, Guo, Zuoming, Wang, Peng, Qu, Zhaowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472048/
https://www.ncbi.nlm.nih.gov/pubmed/37664652
http://dx.doi.org/10.3892/ol.2023.14024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472048/
https://www.ncbi.nlm.nih.gov/pubmed/37664652
http://dx.doi.org/10.3892/ol.2023.14024

Ejemplares similares